Kolexia
Etienne-Grimaldi Marie-Christine Pharmacien
Etienne-Grimaldi Marie-Christine
Pharmacien
Centre Antoine Lacassagne
Nice, France
92 Activités
73 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs de la tête et du cou Tumeurs du sein Déficit en dihydropyrimidine déshydrogénase Carcinome épidermoïde Carcinomes Métastase tumorale Adénocarcinome Carcinome épidermoïde de la tête et du cou

Collaborateurs

Voir plus
Thomas Fabienne
Thomas Fabienne
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Boyer Jean-Christophe
Boyer Jean-Christophe
Hôpital Carémeau, Nîmes, France
Loriot Marie-Anne
Loriot Marie-Anne
Hôpital Européen Georges Pompidou, Paris, France
Thariat Juliette
Thariat Juliette
Centre François-Baclesse, Caen, France

Industries

Voir plus
Amgen
2 collaboration(s)
Dernière en 2020
AstraZeneca
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.
British journal of cancer   15 janvier 2024
Impact of hemolysis on uracilemia in the context of dihydropyrimidine dehydrogenase deficiency testing.
Clinical chemistry and laboratory medicine   11 janvier 2024
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer chemotherapy and pharmacology   13 novembre 2023
Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma.
Current opinion in oncology   14 mars 2023
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer.
Pharmaceutics   15 février 2023
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
European journal of cancer (Oxford, England : 1990)   09 décembre 2022
Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!
Clinical pharmacology and therapeutics   22 novembre 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
British journal of clinical pharmacology   03 octobre 2022
343P DPYD gene sequencing and in silico functionality prediction of polymorphisms in 3,471 colorectal cancer patients treated with fluoropyrimidine (FP)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021